GeneBioTech Co. Ltd (086060) — Working Capital to Net Assets Ratio
GeneBioTech Co. Ltd (086060) has a Working Capital to Net Assets ratio of 73.2% as of September 2025. Working capital of ₩39.57 Billion (current assets of ₩55.19 Billion minus current liabilities of ₩15.63 Billion) is measured against net assets of ₩54.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 086060 equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GeneBioTech Co. Ltd Working Capital to Net Assets (2014–2024)
This chart shows how GeneBioTech Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 73.2%, reflecting working capital of ₩39.57 Billion against net assets of ₩54.03 Billion KRW. Check 086060 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for GeneBioTech Co. Ltd (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for GeneBioTech Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GeneBioTech Co. Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 73.5% | ₩37.47 Billion | ₩50.97 Billion | ₩55.84 Billion | ₩18.36 Billion | ▲ +1.5 pp |
| 2023 | 72.0% | ₩34.77 Billion | ₩48.30 Billion | ₩49.28 Billion | ₩14.51 Billion | ▲ +5.6 pp |
| 2022 | 66.4% | ₩30.35 Billion | ₩45.73 Billion | ₩46.27 Billion | ₩15.92 Billion | ▲ +2.6 pp |
| 2021 | 63.8% | ₩28.04 Billion | ₩43.95 Billion | ₩42.18 Billion | ₩14.14 Billion | ▼ -20.1 pp |
| 2020 | 83.9% | ₩37.79 Billion | ₩45.04 Billion | ₩45.47 Billion | ₩7.68 Billion | ▲ +11.6 pp |
| 2019 | 72.3% | ₩33.92 Billion | ₩46.93 Billion | ₩43.86 Billion | ₩9.94 Billion | ▲ +1.2 pp |
| 2018 | 71.1% | ₩34.10 Billion | ₩47.96 Billion | ₩48.13 Billion | ₩14.03 Billion | ▲ +24.8 pp |
| 2017 | 46.2% | ₩18.73 Billion | ₩40.49 Billion | ₩30.97 Billion | ₩12.25 Billion | ▲ +4.3 pp |
| 2016 | 42.0% | ₩16.37 Billion | ₩39.02 Billion | ₩27.91 Billion | ₩11.53 Billion | ▼ -12.9 pp |
| 2015 | 54.8% | ₩15.80 Billion | ₩28.84 Billion | ₩26.66 Billion | ₩10.85 Billion | ▲ +5.1 pp |
| 2014 | 49.7% | ₩11.64 Billion | ₩23.42 Billion | ₩24.65 Billion | ₩13.01 Billion | — |